Australian Pharma Stock News

A near five hour nationwide outage at Telstra has put a spotlight on just how dependent Australia is on always on connectivity, and what can happen to stocks when that link breaks. When trains, payments and emergency calls stall, investors start rethinking exposure to network risk, regulatory pressure and the cost of building more resilient systems. This article walks through three stocks exposed to the Telstra outage story. One could see opportunity as customers seek redundancy, while two...

PYC Therapeutics Limited recently appointed Mr. Thomas Ulmer as Chief Financial Officer, adding more than 20 years of international biotechnology, pharmaceutical and healthcare leadership to its executive team. Ulmer’s prior experience guiding Immatics N.V. through its NASDAQ listing gives PYC access to finance leadership familiar with cross-border capital markets and public-company standards. We’ll now examine how Ulmer’s international capital markets background, including NASDAQ listing...

Recent commentary on Technology One (ASX:TNE) has focused on its shift to a cloud-based SaaS platform, its recurring revenue profile, and its push into the UK, prompting investors to reassess how the stock is priced. See our latest analysis for Technology One. At around A$30.62, Technology One’s share price has slipped over the past month but is still ahead year to date. The 1 year total shareholder return has declined despite very strong 3 year and 5 year total shareholder returns. This...

Telstra Group (ASX:TLS) is back in the spotlight after recent coverage highlighted its appeal as a defensive communications stock, with attention on network income resilience, capital discipline, and dividend sustainability. See our latest analysis for Telstra Group. After a strong multi year run, with 3 year total shareholder return of 32.20% and 5 year total shareholder return of 61.03%, Telstra Group’s recent 90 day share price decline of 9.06% and softer short term moves suggest momentum...

With inflation trends softening in several regions, bond yields under pressure and oil prices adding new volatility, many investors are looking for income that feels sturdier than a bank deposit yet less fragile than pure growth stocks. That is where Dividend Fortresses come in, targeting stocks that pair yields of more than 5% with business models built to endure choppy macro headlines. This article introduces three of the strongest candidates from the Dividend Fortresses screener and...

Oil prices are back in focus after U.S. strikes on Iranian targets, the end of a ceasefire, and a fresh clampdown on Iranian crude exports pushed Brent and WTI up by more than 5%. For energy investors, that kind of shock can quickly reshape expectations around cash flows, costs, and risk across oil and gas producers. This article looks at how that news links to a curated screener of large, financially solid oil and natural gas stocks, and highlights 3 stocks that appear positively exposed to...

Inflation policy is moving from the background to centre stage, and that matters directly for your portfolio. With governments exploring profit caps, price controls and new taxes on essential services, some stocks now look far more exposed to regulatory risk than others. This article focuses on the news pressure now circling companies in energy, healthcare, education and childcare, and why that matters if you care about protecting capital. Below, you will find 3 stocks from our Inflation...

Virgin Media’s record £28 million Ofcom fine has put customer treatment and regulatory risk firmly back in the spotlight for telecom stocks. When one major operator is punished for obstructive cancellation tactics, investors often reassess which companies might benefit from stricter oversight and shifting customer trust. This article looks at how that news could ripple across larger telecommunications stocks screens, particularly those with stronger health and performance scores. You will see...

When a major network failure at Telstra can stall emergency calls, payments, and freight across Australia in a single day, it underlines how central resilient telecommunications infrastructure has become to everyday life and business continuity. For investors, outages like this can reshape expectations around reliability, backup capacity, and regulatory pressure. This article looks at how that shock filters through to larger companies involved in telecom infrastructure and resilience, and...

New US tariffs on imports from 60 countries are set to ripple through global trade, raising questions about costs, pricing power, and resilience across logistics and supply chain stocks. For investors watching how freight forwarding, shipping, and warehousing companies handle higher friction at the borders, this is a moment to reassess exposure rather than simply react to headlines. This article walks through three stocks from our Logistics and Supply Chain Solutions screener that appear...

Ionic Rare Earths’ grant-backed recycling plans could give this ASX rare earths stock a clearer test of its China-free supply chain thesis.

Energy shocks, war headlines and interest rate uncertainty are back at the center of markets, with Brent crude recently surging over 50% and central banks warning about future supply and inflation risks. When oil, inflation and rates move together, some stocks can benefit from higher pricing power or stronger demand, while others face rising costs or pressure on funding. This article looks at 3 stocks exposed to the current Iran war and rate backdrop, including 2 that may gain from these...

Artificial intelligence in healthcare sits at the crossroads of rising global cost pressures, tighter monetary policy debates, and consumers who still want better treatment and access. While inflation, rates, and commodity shocks keep moving the macro picture, AI-driven diagnostics, remote care, and research tools target long term efficiency gains and more accurate care. The Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, personalise...

Recent attention on Lovisa Holdings (ASX:LOV) centres on its international store expansion, brand development and operational execution, as investors evaluate how these efforts relate to comparable sales and the stock’s recent price move. See our latest analysis for Lovisa Holdings. Lovisa Holdings’ recent 11.01% 1 month share price gain contrasts with a year to date share price decline of 22.57% and a 1 year total shareholder return decline of 23.89%, while 3 and 5 year total shareholder...

Automation pressure at Australian ports is turning into a real test for companies tied to global trade. Dock workers pushing for a 28 hour week with full pay, rising AI adoption and the risk of strikes or disruptions can all feed into higher costs, operational hiccups and changing sentiment around logistics exposed stocks. For investors, this is less about headlines and more about understanding which businesses are most directly exposed to the news and where labor, regulatory and technology...

With inflation signals mixed across regions and interest rate expectations constantly reassessed, many investors are turning to dividend powerhouses for more predictable income. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% yield that appears well covered, growing and stable, which can be especially appealing when bond markets and central bank policy paths feel hard to read. Instead of trying to time every macro twist, you can focus on cash flows...

Australian shares are expected to open lower today, influenced by recent geopolitical tensions in the Middle East and a decline in U.S. semiconductor stocks. In such fluctuating market conditions, investors often look beyond well-known names to discover opportunities among smaller or newer companies. Although the term "penny stock" might seem outdated, these investments can still offer substantial value when backed by solid financials and potential for growth.

Insiders who bought AU$1.47m worth of OpenLearning Limited ( ASX:OLL ) stock in the last year have seen some of their...

Penny stocks often carry a reputation for high risk, but the Financially Fit Penny Stocks screener targets a narrower corner of this space, focusing on companies trading below 5 that also show signs of solid financial health. With investors watching inflation pressures, interest rate expectations and mixed growth signals across major economies, balance sheet strength and funding resilience matter more than ever. This screener aims to filter for those qualities so you can focus on potential...

Insiders who purchased AU$3.43m worth of DigitalX Limited ( ASX:DCC ) shares over the past year recouped some of their...

Betmakers Technology Group Ltd ( ASX:BET ), might not be a large cap stock, but it saw a double-digit share price rise...

With inflation trends, interest rate expectations and energy prices all pulling markets in different directions, many investors are looking for opportunities where cash flows and valuation still line up in a sensible way. The Undervalued Stocks Based On Cash Flows screener focuses on companies that SWS DCF valuation suggests are trading below fair value, which can appeal if you care about what a business earns in cash rather than headlines. In this article, you will see 3 stocks from this...

Earlier this month, Commonwealth Bank of Australia outlined a slower domestic economic outlook, with its economists projecting A$ GDP growth of about 1.5% in 2026 as softer housing markets and steady interest rates weigh on household spending. At the same time, CBA’s status as Australia’s largest listed bank and a core bluechip is drawing renewed attention as investors refocus on earnings resilience, margins and execution quality over short-term themes. We’ll now explore how this softer...

Elsight (ASX:ELS) drew fresh attention after a 3.11% share price move as investors focused on its role providing connectivity solutions for autonomous and remotely operated systems, particularly drones operating beyond the operator’s line of sight. See our latest analysis for Elsight. The 13.38% 7 day share price return and 15.83% 90 day share price return build on Elsight’s strong year to date momentum of 135.38%, while the 1 year total shareholder return above 400% underlines how sentiment...